Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBA, Safety and Tolerability of Ganfeborole in Pulmonary Tuberculosis
NCT03557281Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ganfeborole in pulmonary tuberculosis (TB), sponsored by GSK. Started Mar 2019; status: completed.
02
Drugs
ganfeborole
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT03557281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03557281.